Angelman Syndrome clinical trials

Explore recruiting angelman syndrome clinical trials.

Recruiting angelman syndrome studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Angelman Syndrome trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ION582-CS1: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ION582 in Patients with Angelman Syndrome

France, Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 2, Open-label, Basket Study Investigating the Safety and Efficacy of GTX-102 in Adult and Pediatric Subjects with Deletion- or Nondeletion-type Angelman Syndrome

Portugal, Italy, France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Long-Term Extension Trial Investigating the Safety and Efficacy of GTX-102 in Patients with Angelman Syndrome

France, Spain, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Randomized, Double-blind, Sham-controlled Study Investigating the Efficacy and Safety of GTX-102 in Pediatric Subjects with Angelman Syndrome

Netherlands, Spain, Germany, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

REVEAL Study: Phase 3 Study of the Efficacy and Safety of ION582 in Children and Adults with Angelman Syndrome

Italy, Germany, Poland, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Open-Label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7248824 In Participants with Angelman Syndrome

Netherlands, Italy, Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

Angelman Syndrome trials by city

Angelman Syndrome in Toronto Angelman Syndrome in Vancouver Angelman Syndrome in Montreal Angelman Syndrome in Calgary Angelman Syndrome in Edmonton Angelman Syndrome in Ottawa Angelman Syndrome in Winnipeg Angelman Syndrome in Quebec City Angelman Syndrome in Hamilton Angelman Syndrome in Kitchener Angelman Syndrome in London Angelman Syndrome in Halifax Angelman Syndrome in New York Angelman Syndrome in Los Angeles Angelman Syndrome in Chicago Angelman Syndrome in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease